COVID-19 mRNA 백신은 임상시험에서 약 94–95%의 효능을 보였으며, 2022년까지 전 세계적으로 130억 회 이상 투여되었습니다. mRNA 백신은 지질 나노입자에 캡슐화된 mRNA를 세포질에 전달하여, 세포가 바이러스 항원을 생성한 후 스스로 파괴하도록 지시합니다. 이 과정에서 mRNA는 핵에 들어가거나 DNA를 변경하지 않습니다. 2005년 카탈린 카리코와
매년 전 세계적으로 1억 마리 이상의 동물이 실험실 실험에 사용됩니다. 동물에서 유망해 보였던 약물 후보의 약 90%가 인간 임상시험에서 실패합니다. Organ-on-a-chip은 살아있는 인간 세포로 덮인 미세한 중공 채널과 혈관 흐름을 모사하는 칩으로, 심장, 폐, 간 등 주요 장기의 기능을 재현합니다. 폐 칩은
2012년 Dr. Jennifer Doudna와 Dr. Emmanuelle Charpentier가 CRISPR/Cas9 시스템이 시험관 내에서 DNA를 편집할 수 있음을 입증하는 획기적 논문을 발표했다. 2016년 중국에서 CRISPR로 편집한 면역세포를 이용해 암을 치료하는 최초의 인간 임상시험이 시작됐다. 2019년 미국에서 첫 CRISPR 임상시험이 시작되었고 겸상적혈구빈혈 환자 빅토리 그레이가 치료를
Luxturna(voretigene neparvovec)는 2017년 FDA에서 최초의 유전자 치료제로 승인되어 RPE65 관련 망막이상증을 1회 망막 아래 주사로 치료합니다. Casgevy(exagamglogene autotemcel)는 2023년 CRISPR 기반 치료제로 최초 승인되어 겸상적혈구병과 수혈 의존 베타 지중해빈혈에 대해 1회 치료로 환자 조혈모세포를 편집해 태아 헤모글로빈 생성을 증가시킵니다. Hemgenix(etranacogene dezaparvovec)는 2022년
November 23, 2025, 1:20 AM EST. Microsoft is expanding the Xbox Full Screen Experience (FSE) beyond its handhelds to laptops, desktops, and tablets. The feature, which adds a console-like UI to your game library, originally launched with the Xbox Ally and is now rolling out via Windows Insider Preview builds on the Dev and Beta channels. To enable it, hover over the Task View icon and choose Xbox full screen experience, open it in Game Bar > Settings, or press Win + F11. Availability is gradual, and you'll need the Xbox app from the Microsoft Store and enrollment in the Xbox Insider Program. As of now, FSE is expanding to all Windows handhelds as part of Microsoft's push to unify the Xbox experience across devices.
November 23, 2025, 1:16 AM EST. Quantum stocks have been hammered during this tech pullback, with speculative names giving back big gains after a blistering rally. While the AI trade has cooled, there may still be entry points for risk-tolerant investors. Nvidia's blowout helped spark the moment, and its NVQLink could offer exposure to quantum gains without the deepest plunge. For pure-play quantum names, D-WaveQBTS could test support around $18-20, but a break below could signal further downside. For those seeking less volatility, IBM offers a more mature path with a clear quantum roadmap and recent launches like Quantum Nighthawk and Quantum Loom, appealing to investors seeking a quantum advantage with steadier exposure. Overall, expect 50%+ drawdowns in this space; size risk accordingly.
November 23, 2025, 1:14 AM EST. Gmail's latest update brings AI-powered tools to the inbox, but users are being warned to opt out of data collection that could train AI models. A viral post on X claimed users are automatically opted in to allow Gmail to access private messages and attachments for training, with a two-step opt-out in Settings. Google has not publicly commented, but reports note that features like Smart Compose, Smart Reply, enhanced search, and stronger spam detection rely on analyzing inbox content and metadata. Users can decline the update, though doing so may reduce functionality. The controversy highlights the ongoing privacy debate as tech firms balance convenience against data usage for AI training.
November 23, 2025, 1:12 AM EST. Microsoft is rolling out the Xbox Full Screen Experience (FSE) to Windows-based handhelds starting November 21, delivering a console like UI on Windows 11 devices. The FSE runs without the full Windows desktop, saving about 2GB of memory by skipping the Explorer shell. On launch, devices boot into the Xbox PC app, surfacing games from the Microsoft Store, Battle.net, Steam, and other storefronts, with a Game Bar and a handheld friendly task view for quick switching. To enable, go to Settings > Gaming > Full screen experience and choose Xbox as your home app. Microsoft is expanding FSE to more Windows 11 PC form factors through the Xbox and Windows Insider programs after a preview on MSI Claw devices. A tighter, more console like experience for portable Windows gaming.
November 23, 2025, 1:10 AM EST. Google is rolling out Gmail upgrades powered by Gemini AI, promising faster emails and smarter inbox management. The rollout has triggered a privacy backlash as users discover automatic opt-ins that allow Gmail to access private messages and attachments to train AI models. Some reports claim default-on settings persist even when users expect opt-in controls, raising concerns about data harvesting and the broader AI race. Google asserts that basic privacy commitments stay intact, but the fine print matters, especially for those outside regions where smart features ship with defaults off. The update underscores the difficulty of navigating privacy policies, opt-ins, and inertia across tools from Google and competitors. Users should review the two required settings to decide whether to enable or disable AI-assisted features.